Gilead Sciences, Inc. (GILD) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

91% of 23 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 03/27/2015 1 month $101.62 $99.25 -2.33% 2 Active
Comments:
EnergyBug EnergyBug 03/24/2015 3 months $102.21 $99.25 -2.9% -2 Active
Comments: Resistance at 102. SOLID fundamentals + YOY 75% EPS growth
Butler1 Butler1 03/04/2015 3 months $103.06 $99.25 -3.7% -3 Active
Comments:
KhurshedAli KhurshedAli 03/02/2015 1 day $103.51 $102.79 -0.7% 1 Ended
Comments:
Razmik (Rick) Khachatryan Razmik (Rick) Khachatryan 02/24/2015 3 months $104.60 $99.25 -5.11% 5 Active
Comments: Coz i thing is down time ,for me...
opaque/f4775caa-b177-11e4-94fa-13973a5a9c77 opaque/f4775caa-b177-11e4-94fa-13973a5a9c77 02/23/2015 1 Year $102.61 $99.25 -3.27% -3 Active
Comments: This is a well managed company This stock is undervalued
abievabay abievabay 02/16/2015 1 month $101.90 $99.61 -2.25% -2 Ended
Comments:
dbnosh dbnosh 02/16/2015 3 months $101.90 $99.25 -2.6% -2 Active
Comments: Reserves of cash, best HepC and HIV treatments on the market and a pipeline worth waiting for
02/12/2015 3 months $100.73 $99.25 -1.47% -1 Active
Comments:
usenasdaqok usenasdaqok 02/12/2015 3 months $100.60 $99.25 -1.34% -1 Active
Comments: It's undervalued
Donce Donce 02/02/2015 3 months $104.83 $99.25 -5.32% -5 Active
Comments: This is well managed company
ArtMutiaManliguez ArtMutiaManliguez 01/28/2015 1 Year $104.20 $99.25 -4.75% -4 Active
Comments: Upcoming product launch will be successful
wdm9128 wdm9128 01/14/2015 3 months $99.07 $99.25 +0.18% 1 Active
Comments:
Jhonnyk Jhonnyk 01/13/2015 1 week $101.21 $100.71 -0.49% -1 Ended
Comments: Will get close to the 110 short term. long term too complicated.
yitzbr yitzbr 01/05/2015 1 Year $94.91 $99.25 +4.57% 4 Active
Comments:
Umair Javaid Umair Javaid 12/25/2014 3 months $91.29 $101.41 +11.09% 11 Ended
Comments:
davidburnfield davidburnfield 12/19/2014 1 Year $109.40 $99.25 -9.28% -9 Active
Comments: This is a well run company with a blockbuster drug - Harvoni - and more in the pipeline.
floydc floydc 12/02/2014 1 Year $102.19 $99.25 -2.88% -2 Active
Comments: Outstanding research
MirelaTushe MirelaTushe 12/01/2014 1 week $100.92 $101.82 +0.89% 1 Ended
Comments:
g_tharp g_tharp 11/10/2014 3 months $107.06 $97.48 -8.95% -8 Ended
Comments:
Displaying 1-20 of 61
<< first < previous 1 2 3 4 last >>

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.